Continued from page 1
Drug Therapy: A drug called Alimta, developed by Eli Lilly, has been shown to significantly increase
life expectancy of patients and decrease symptoms of
disease. It is
only chemotherapy drug to be approved by
Food and Drug Administration for
treatment of patients with malignant pleural mesothelioma.
Gene Therapy: This mesothelioma treatment is currently in
experimental stages. The process involves inserting a "suicide gene" directly into
tumor. This gene makes
cells sensitive to a normally ineffective drug called glanciclovir which destroys all
cancer cells and leaves
healthy cells unharmed.
Photodynamic Therapy: Still in its experimental stage, photodynamic therapy uses light to kill cancerous cells. The patient first receives a photosensitizer that only collects in cancerous cells. Fiberoptic cables are then placed in
body in order to focus
right frequency of light on
tumor. The photosensitizer is then caused to produce a toxic oxygen molecule that kills
cancer cell.
Immunotherapy: Also referred to as biological therapy, this mesothelioma treatment uses
body's personal immune system to defend itself against mesothelioma. It has been discovered that
immune system is capable of deciphering healthy cells from cancerous cells, and can thus eradicate those cells that cause cancer.
While treatment methods are still in
developmental or experimental stages, there is hope that one day all mesothelioma victims will be freed from
murderous hands of this fearsome disease.

Maggie Kay is a freelance writer from Montreal and is the head researcher and content manager of Mesothelioma Attorney Advice Center (www.maacenter.org).